Deltasone: Potent Systemic Corticosteroid for Effective Inflammation Control
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.79 | $47.37 (0%) | 🛒 Add to cart |
| 90 | $0.65 | $71.06 $58.46 (18%) | 🛒 Add to cart |
| 120 | $0.59 | $94.74 $70.55 (26%) | 🛒 Add to cart |
| 180 | $0.52 | $142.12 $93.74 (34%) | 🛒 Add to cart |
| 270 | $0.48 | $213.17 $130.02 (39%) | 🛒 Add to cart |
| 360 | $0.46
Best per pill | $284.23 $165.30 (42%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.92 | $55.44 (0%) | 🛒 Add to cart |
| 90 | $0.85 | $83.15 $76.60 (8%) | 🛒 Add to cart |
| 120 | $0.81 | $110.87 $97.77 (12%) | 🛒 Add to cart |
| 180 | $0.77 | $166.31 $138.08 (17%) | 🛒 Add to cart |
| 270 | $0.75 | $249.46 $202.59 (19%) | 🛒 Add to cart |
| 360 | $0.73
Best per pill | $332.61 $262.06 (21%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.04 | $62.49 (0%) | 🛒 Add to cart |
| 90 | $0.95 | $93.74 $85.67 (9%) | 🛒 Add to cart |
| 120 | $0.91 | $124.98 $108.86 (13%) | 🛒 Add to cart |
| 180 | $0.87 | $187.47 $156.23 (17%) | 🛒 Add to cart |
| 270 | $0.85 | $281.21 $228.80 (19%) | 🛒 Add to cart |
| 360 | $0.83
Best per pill | $374.95 $298.34 (20%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.33 | $59.47 (0%) | 🛒 Add to cart |
| 270 | $0.30 | $89.20 $81.64 (8%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $118.93 $104.82 (12%) | 🛒 Add to cart |
Synonyms | |||
Deltasone, with its active ingredient prednisone, is a cornerstone systemic corticosteroid medication prescribed for managing a wide array of inflammatory and autoimmune conditions. It functions by mimicking the effects of cortisol, a hormone naturally produced by the adrenal glands, to suppress the immune system’s overactive responses and reduce widespread inflammation. This medication is a critical tool in the therapeutic arsenal for specialists managing complex immunological disorders, severe allergic reactions, and certain malignancies. Its efficacy is well-documented in clinical practice, offering significant symptomatic relief and disease modification when used under precise medical supervision.
Features
- Active Ingredient: Prednisone
- Drug Class: Synthetic glucocorticoid corticosteroid
- Administration: Oral tablet
- Available Strengths: 1mg, 2.5mg, 5mg, 10mg, 20mg, 50mg
- Bioavailability: High oral bioavailability with rapid conversion to active prednisolone in the liver
- Half-life: Biological half-life of 18-36 hours
- Onset of Action: Systemic effects typically begin within 1-2 hours post-ingestion
- Metabolism: Hepatic, primarily via CYP3A4 enzyme system
- Excretion: Renal elimination of inactive metabolites
Benefits
- Provides rapid and potent suppression of inflammatory mediators including cytokines, prostaglandins, and leukotrienes
- Effectively manages symptoms across multiple body systems by reducing tissue edema, capillary permeability, and leukocyte migration
- Induces remission in autoimmune disorders by modulating aberrant immune cell function and antibody production
- Prevents and controls chemotherapy-induced nausea and vomiting when used in antiemetic protocols
- Serves as immunosuppressive therapy in organ transplantation to prevent rejection episodes
- Can be life-saving in acute adrenal insufficiency and severe anaphylactic reactions
Common use
Deltasone is indicated for a broad spectrum of medical conditions requiring anti-inflammatory or immunosuppressive intervention. In rheumatology, it is fundamental for managing active rheumatoid arthritis, systemic lupus erythematosus, polymyalgia rheumatica, and giant cell arteritis. Pulmonologists utilize it for severe asthma exacerbations, sarcoidosis, and chronic obstructive pulmonary disease flare-ups. In dermatology, it treats severe psoriasis, pemphigus vulgaris, and severe allergic contact dermatitis. Hematologists prescribe it for autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura, and as part of combination chemotherapy regimens for certain leukemias and lymphomas. Additionally, it is used in nephrology for various glomerulonephritides, in gastroenterology for inflammatory bowel disease exacerbations, and in neurology for multiple sclerosis relapses and myasthenia gravis crises.
Dosage and direction
Dosage must be individualized based on disease severity, patient response, and the specific condition being treated. For anti-inflammatory effects, initial doses typically range from 5-60mg daily, often administered as a single morning dose to coincide with the body’s natural cortisol rhythm. Higher doses may be required for immunosuppressive effects in autoimmune conditions or organ transplantation. For adrenal insufficiency, physiological replacement doses are typically 4-5mg/m² daily. Always take with food or milk to minimize gastrointestinal irritation. Do not crush, chew, or break delayed-release formulations. The timing of administration is critical—taking the medication in the morning helps reduce the impact on the hypothalamic-pituitary-adrenal axis. Never discontinue abruptly after prolonged use; gradual tapering under medical supervision is essential to prevent adrenal insufficiency.
Precautions
Patients requiring Deltasone therapy require careful monitoring throughout treatment. Baseline and periodic assessments should include blood pressure, weight, ocular pressure, glucose tolerance, electrolyte levels, and bone density evaluation in long-term users. Those with cardiovascular risk factors should be monitored for fluid retention, hypertension, and congestive heart failure. Diabetic patients will likely require adjustment of hypoglycemic agents due to Deltasone’s hyperglycemic effects. Monitor for signs of infection as immunosuppression may mask typical symptoms. Psychological status should be assessed regularly due to potential mood disturbances. Pediatric patients require close growth monitoring, while postmenopausal women should be evaluated for accelerated bone loss. Vaccination with live vaccines is generally contraindicated during therapy.
Contraindications
Deltasone is absolutely contraindicated in patients with known hypersensitivity to prednisone or any component of the formulation. Systemic fungal infections represent another absolute contraindication due to the risk of disseminated infection. Live virus vaccinations should not be administered to individuals receiving immunosuppressive doses. Relative contraindications include active or latent tuberculosis, active herpes simplex keratitis, peptic ulcer disease, osteoporosis, uncontrolled hypertension, congestive heart failure, diabetes mellitus, psychotic tendencies, and pregnancy—particularly during the first trimester due to potential teratogenic effects. The risk-benefit ratio must be carefully considered in patients with these conditions.
Possible side effect
Corticosteroid therapy, including Deltasone, is associated with a wide range of potential adverse effects that often correlate with dosage and duration of treatment. Common reactions include fluid retention, weight gain, hypertension, glucose intolerance, increased appetite, and mood changes such as euphoria or depression. Gastrointestinal effects may include peptic ulceration, pancreatitis, and abdominal distension. Musculoskeletal complications encompass osteoporosis, vertebral compression fractures, aseptic necrosis of femoral and humeral heads, muscle weakness, and steroid myopathy. Dermatological manifestations include impaired wound healing, petechiae, ecchymoses, facial erythema, and hirsutism. Ophthalmic effects can include posterior subcapsular cataracts, increased intraocular pressure, and glaucoma. Endocrine disturbances may manifest as hypothalamic-pituitary-adrenal axis suppression, Cushingoid state, growth suppression in children, and menstrual irregularities. Metabolic effects include hyperlipidemia, negative nitrogen balance, and hypokalemic alkalosis.
Drug interaction
Deltasone exhibits numerous clinically significant drug interactions that require careful management. Concurrent use with CYP3A4 inducers such as phenobarbital, phenytoin, or rifampin may increase prednisone clearance, reducing its efficacy. Conversely, CYP3A4 inhibitors like ketoconazole or erythromycin may increase prednisone levels and toxicity risk. Anticoagulant effects may be altered, requiring more frequent INR monitoring with warfarin. Concurrent NSAID use significantly increases the risk of gastrointestinal ulceration. Deltasone may antagonize the effects of antihypertensive and hypoglycemic agents. Potassium-depleting diuretics may exacerbate hypokalemia, while concurrent use with amphotericin B increases the risk of cardiac enlargement and congestive heart failure. The immunosuppressive effects may diminish the efficacy of vaccinations and increase the risk of disseminated infection with live vaccines.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. For patients on alternate-day therapy, if a dose is missed, contact the prescribing physician for guidance as the dosing schedule may need adjustment. Consistent timing is particularly important for patients with adrenal insufficiency who rely on replacement therapy. Those taking multiple daily doses should maintain as regular a schedule as possible to maintain stable drug levels. If uncertain about how to handle a missed dose, always consult the prescribing healthcare provider rather than making independent decisions.
Overdose
Acute overdose with Deltasone is unlikely to produce life-threatening symptoms in the short term, but may exacerbate dose-dependent adverse effects. Manifestations may include severe hypertension, hypokalemia, hyperglycemia, fluid retention, and psychiatric disturbances including psychosis. There is no specific antidote for prednisone overdose. Management is supportive and symptomatic, including gastric lavage or activated charcoal if ingestion was recent. Electrolyte imbalances should be corrected, particularly hypokalemia. Blood glucose should be monitored and managed appropriately. Hypertension may require antihypertensive therapy. In cases of chronic excessive administration, gradual dose reduction is necessary to avoid adrenal insufficiency. Patients should be monitored for signs of adrenal crisis during dose reduction. Dialysis is not effective due to high protein binding.
Storage
Store Deltasone tablets at controlled room temperature between 20-25°C (68-77°F), with excursions permitted between 15-30°C (59-86°F). Protect from light, moisture, and excessive heat. Keep the container tightly closed and ensure the desiccant remains in the bottle if provided. Do not store in bathrooms or other areas with high humidity. Keep all medications out of reach of children and pets. Do not transfer tablets to other containers unless specifically designed for medication storage. Properly discard any medication that has expired or is no longer needed through medication take-back programs or according to FDA guidelines. Do not flush medications down the toilet unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Deltasone is a prescription medication that should be used only under the supervision of a qualified healthcare professional. The prescribing physician will determine the appropriate dosage and duration based on individual patient factors. Do not initiate, adjust, or discontinue this medication without consulting your healthcare provider. The information presented here may not include all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about this medication, talk to your doctor, pharmacist, or other healthcare provider. In case of emergency or suspected overdose, contact poison control or emergency services immediately.
Reviews
Clinical studies and patient experiences consistently demonstrate Deltasone’s efficacy in controlling inflammatory and autoimmune conditions. Rheumatologists report significant improvement in disease activity scores in approximately 70-80% of rheumatoid arthritis patients within 2-4 weeks of initiation. Pulmonologists note rapid improvement in lung function and symptom control in severe asthma exacerbations, often within 24-48 hours. Dermatologists observe clearing of severe dermatoses in most patients within 1-3 weeks. The most frequently reported challenges in patient reviews include weight gain (reported in ~50% of long-term users), mood disturbances (~30%), and difficulty with dose reduction due to return of symptoms. Many patients describe Deltasone as “life-changing” for controlling debilitating symptoms while acknowledging the management challenges associated with side effects. Success appears highest when used for appropriate indications with careful monitoring and gradual tapering protocols.